Special Issue "Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications 2.0"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: 30 November 2020.
Interests: In the organic chemistry field: synthesis and characterization of new bioactive compounds; sustainable chemistry; biotransformations. In the natural products field: isolation and characterization of secondary metabolites, assessment of their activities, chemical transformation, and total synthesis
Special Issues and Collections in MDPI journals
Special Issue in Marine Drugs: Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications
Topical Collection in Methods and Protocols: Green Chemistry
Special Issue in Molecules: Marine and Terrestrial Sources of Natural Products: Chemical Composition Profiling, Isolation and Characterization
Although the use of seaweeds in gastronomy is increasing, in many countries, they are still considered unconventional food plants. Scientific evidence of their nutritional value and their health benefits is still needed and numerous researchers are dedicated to establishing the health and nutritional potential of seaweeds. Moreover, scientific research has gone further and, recently, efforts to establish the relationship between the secondary metabolites of seaweeds and health and nutritional effects have been explored.
The Special Issue "Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications” has been a success and we think that more interesting results are being achieved; therefore, a second Special Issue of Marine Drugs dedicated to this subject, seems to be essential. The Special Issue "Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications 2.0” welcomes high-quality manuscripts exploring bioactive compounds from seaweeds and their therapeutic applications.
As Guest Editor, I invite scientists to submit their latest research findings and review articles in this area and contribute interesting papers with significant advances in this field to this Special Issue of Marine Drugs.
Prof. Dr. Diana Cláudia Pinto
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Secondary Metabolites
- Biological Activities
- Nutritional Supplements
- Drug delivery
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Article type: Review
Title: Phlorotannins from Brown Seaweeds (Ochrophyta, Phaeophyceae): In the Pursuit of Natural Alternatives to Tackle Neurodegeneration
Authors: Mariana Barbosa; Patrícia Valentão; Paula B. Andrade *
Affiliation: REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira n.º 228, Porto 4050-313, Portugal
Corresponding author: Paula B. Andrade
Abstract: Globally, the burden of neurodegenerative disorders continues to rise, and their multifactorial etiology has been regarded as among the most challenging medical issue. Bioprospecting for seaweed-derived multimodal acting products have then earned increasing attention in the fight against neurodegenerative conditions. Phlorotannins (phloroglucinol-based polyphenols exclusively produced by brown seaweeds) are amongst the most promising nature-sourced compounds in terms of functionality, and though research on their neuroprotective properties is still in its infancy, phlorotannins have been found to modulate intricate events within the neuronal network. This review comprehensively covers the available literature on the neuroprotective potential of both isolated phlorotannins and phlorotannin-rich extracts/fractions, highlighting the main key findings and pointing some potential directions for neuro research ramp-up process on these marine-derived products.